Ocular Therapeutix, Inc.OCULNASDAQ
Loading
EBITDA Margin Over TimeContracting
Percentile Rank67
Studio
Year-over-Year Change

EBITDA as a percentage of revenue

Latest
-480.80%
↑ 59% vs avg
Percentile
P67
Within normal range
Streak
2 yr
Consecutive declineContracting
Average
-1182.22%
Historical baseline
PeriodValueYoY Change
TTM-480.80%-73.9%
2024-276.42%-143.2%
2023-113.64%+5.5%
2022-120.22%-2160.8%
20215.83%+100.7%
2020-839.48%+54.4%
2019-1839.15%+34.6%
2018-2811.71%+9.7%
2017-3113.31%-39.4%
2016-2233.28%-